United States · FDA National Drug Code directory
Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-283_6842c7a1-52e9-4047-81e1-22da3ec35505
- Product NDC
- 50742-283
- Form
- CAPSULE
- Composition / generic term
- Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
- Labeler
- Ingenus Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230704
- Source listing expiry
- 20261231
Source-listed ingredients
- BISMUTH SUBCITRATE POTASSIUM — 140 mg/1
- METRONIDAZOLE — 125 mg/1
- TETRACYCLINE HYDROCHLORIDE — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE in 1 CARTON (50742-283-13) · 50742-283-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →